nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—P2RY12—systemic lupus erythematosus	0.713	1	CbGaD
Epoprostenol—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0201	0.402	CbGbCtD
Epoprostenol—CYP2C9—Dapsone—systemic lupus erythematosus	0.0143	0.286	CbGbCtD
Epoprostenol—CYP2C9—cardial valve—systemic lupus erythematosus	0.0111	0.181	CbGeAlD
Epoprostenol—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0094	0.188	CbGbCtD
Epoprostenol—PTGIS—endothelium—systemic lupus erythematosus	0.00685	0.112	CbGeAlD
Epoprostenol—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00619	0.124	CbGbCtD
Epoprostenol—P2RY12—blood plasma—systemic lupus erythematosus	0.00548	0.0896	CbGeAlD
Epoprostenol—Treprostinil—P2RY12—systemic lupus erythematosus	0.00426	1	CrCbGaD
Epoprostenol—PTGIR—endothelium—systemic lupus erythematosus	0.00394	0.0644	CbGeAlD
Epoprostenol—PTGIR—blood plasma—systemic lupus erythematosus	0.00349	0.0572	CbGeAlD
Epoprostenol—PTGIS—connective tissue—systemic lupus erythematosus	0.00324	0.053	CbGeAlD
Epoprostenol—PTGER1—kidney—systemic lupus erythematosus	0.00256	0.0419	CbGeAlD
Epoprostenol—CYP2C9—urine—systemic lupus erythematosus	0.00239	0.0391	CbGeAlD
Epoprostenol—PTGIS—tendon—systemic lupus erythematosus	0.00223	0.0364	CbGeAlD
Epoprostenol—PTGIS—lung—systemic lupus erythematosus	0.00195	0.032	CbGeAlD
Epoprostenol—PTGIR—connective tissue—systemic lupus erythematosus	0.00186	0.0304	CbGeAlD
Epoprostenol—PTGIS—nervous system—systemic lupus erythematosus	0.00181	0.0296	CbGeAlD
Epoprostenol—PTGIS—central nervous system—systemic lupus erythematosus	0.00174	0.0285	CbGeAlD
Epoprostenol—PTGER1—nervous system—systemic lupus erythematosus	0.00168	0.0275	CbGeAlD
Epoprostenol—P2RY12—nervous system—systemic lupus erythematosus	0.00163	0.0267	CbGeAlD
Epoprostenol—PTGER1—central nervous system—systemic lupus erythematosus	0.00162	0.0265	CbGeAlD
Epoprostenol—PTGIR—kidney—systemic lupus erythematosus	0.00158	0.0259	CbGeAlD
Epoprostenol—P2RY12—central nervous system—systemic lupus erythematosus	0.00157	0.0257	CbGeAlD
Epoprostenol—CYP2C9—blood plasma—systemic lupus erythematosus	0.00125	0.0204	CbGeAlD
Epoprostenol—PTGIR—lung—systemic lupus erythematosus	0.00112	0.0184	CbGeAlD
Epoprostenol—PTGIR—nervous system—systemic lupus erythematosus	0.00104	0.017	CbGeAlD
Epoprostenol—PTGIR—central nervous system—systemic lupus erythematosus	0.001	0.0164	CbGeAlD
Epoprostenol—PTGIS—Adipogenesis—TNF—systemic lupus erythematosus	0.000122	0.00213	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000122	0.00212	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000117	0.00204	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000117	0.00204	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000114	0.00199	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000112	0.00195	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000112	0.00195	CbGpPWpGaD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000109	0.0019	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IFNA1—systemic lupus erythematosus	0.000109	0.00189	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000109	0.00189	CbGpPWpGaD
Epoprostenol—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000108	0.000943	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	0.000108	0.00187	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000942	CcSEcCtD
Epoprostenol—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000107	0.000941	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000107	0.000939	CcSEcCtD
Epoprostenol—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000935	CcSEcCtD
Epoprostenol—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000106	0.000928	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000106	0.00185	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.000928	CcSEcCtD
Epoprostenol—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000105	0.000924	CcSEcCtD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000105	0.00183	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000105	0.00183	CbGpPWpGaD
Epoprostenol—Myalgia—Betamethasone—systemic lupus erythematosus	0.000105	0.000921	CcSEcCtD
Epoprostenol—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000105	0.000921	CcSEcCtD
Epoprostenol—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000105	0.00092	CcSEcCtD
Epoprostenol—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000105	0.00092	CcSEcCtD
Epoprostenol—Anxiety—Betamethasone—systemic lupus erythematosus	0.000105	0.000918	CcSEcCtD
Epoprostenol—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000105	0.000918	CcSEcCtD
Epoprostenol—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000104	0.00091	CcSEcCtD
Epoprostenol—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000104	0.000909	CcSEcCtD
Epoprostenol—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000908	CcSEcCtD
Epoprostenol—Pain—Prednisolone—systemic lupus erythematosus	0.000103	0.000905	CcSEcCtD
Epoprostenol—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000103	0.000905	CcSEcCtD
Epoprostenol—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.000902	CcSEcCtD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000103	0.00179	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000103	0.00179	CbGpPWpGaD
Epoprostenol—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000103	0.000899	CcSEcCtD
Epoprostenol—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000103	0.000898	CcSEcCtD
Epoprostenol—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.000897	CcSEcCtD
Epoprostenol—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.000897	CcSEcCtD
Epoprostenol—Nausea—Leflunomide—systemic lupus erythematosus	0.000102	0.000895	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000102	0.000893	CcSEcCtD
Epoprostenol—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000102	0.000891	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000101	0.000887	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000885	CcSEcCtD
Epoprostenol—Pain—Hydrocortisone—systemic lupus erythematosus	0.000101	0.000884	CcSEcCtD
Epoprostenol—Oedema—Dexamethasone—systemic lupus erythematosus	0.000101	0.000883	CcSEcCtD
Epoprostenol—Oedema—Betamethasone—systemic lupus erythematosus	0.000101	0.000883	CcSEcCtD
Epoprostenol—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000101	0.000883	CcSEcCtD
Epoprostenol—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000101	0.000883	CcSEcCtD
Epoprostenol—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000101	0.00088	CcSEcCtD
Epoprostenol—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.0001	0.000879	CcSEcCtD
Epoprostenol—Infection—Dexamethasone—systemic lupus erythematosus	0.0001	0.000878	CcSEcCtD
Epoprostenol—Infection—Betamethasone—systemic lupus erythematosus	0.0001	0.000878	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—IFNA1—systemic lupus erythematosus	0.0001	0.00174	CbGpPWpGaD
Epoprostenol—Paraesthesia—Triamcinolone—systemic lupus erythematosus	9.98e-05	0.000874	CcSEcCtD
Epoprostenol—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	9.96e-05	0.000872	CcSEcCtD
Epoprostenol—Anaemia—Prednisone—systemic lupus erythematosus	9.94e-05	0.000871	CcSEcCtD
Epoprostenol—Shock—Dexamethasone—systemic lupus erythematosus	9.92e-05	0.000869	CcSEcCtD
Epoprostenol—Shock—Betamethasone—systemic lupus erythematosus	9.92e-05	0.000869	CcSEcCtD
Epoprostenol—Dyspnoea—Triamcinolone—systemic lupus erythematosus	9.91e-05	0.000868	CcSEcCtD
Epoprostenol—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	9.89e-05	0.000866	CcSEcCtD
Epoprostenol—Nervous system disorder—Betamethasone—systemic lupus erythematosus	9.89e-05	0.000866	CcSEcCtD
Epoprostenol—Agitation—Prednisone—systemic lupus erythematosus	9.89e-05	0.000866	CcSEcCtD
Epoprostenol—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	9.87e-05	0.000865	CcSEcCtD
Epoprostenol—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	9.87e-05	0.000865	CcSEcCtD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	9.87e-05	0.00172	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—IL6—systemic lupus erythematosus	9.86e-05	0.00172	CbGpPWpGaD
Epoprostenol—Tachycardia—Betamethasone—systemic lupus erythematosus	9.84e-05	0.000862	CcSEcCtD
Epoprostenol—Tachycardia—Dexamethasone—systemic lupus erythematosus	9.84e-05	0.000862	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	9.82e-05	0.00171	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	9.82e-05	0.00171	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	9.81e-05	0.00171	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	9.78e-05	0.000857	CcSEcCtD
Epoprostenol—Dyspepsia—Triamcinolone—systemic lupus erythematosus	9.78e-05	0.000857	CcSEcCtD
Epoprostenol—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	9.76e-05	0.000855	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—RASGRP1—systemic lupus erythematosus	9.75e-05	0.0017	CbGpPWpGaD
Epoprostenol—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	9.75e-05	0.000854	CcSEcCtD
Epoprostenol—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	9.75e-05	0.000854	CcSEcCtD
Epoprostenol—PTGIS—Disease—HIST2H2AC—systemic lupus erythematosus	9.71e-05	0.00169	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	9.65e-05	0.000845	CcSEcCtD
Epoprostenol—Syncope—Prednisone—systemic lupus erythematosus	9.65e-05	0.000845	CcSEcCtD
Epoprostenol—Anorexia—Dexamethasone—systemic lupus erythematosus	9.61e-05	0.000842	CcSEcCtD
Epoprostenol—Anorexia—Betamethasone—systemic lupus erythematosus	9.61e-05	0.000842	CcSEcCtD
Epoprostenol—Urticaria—Prednisolone—systemic lupus erythematosus	9.6e-05	0.000841	CcSEcCtD
Epoprostenol—Cardiac disorder—Methotrexate—systemic lupus erythematosus	9.59e-05	0.00084	CcSEcCtD
Epoprostenol—Fatigue—Triamcinolone—systemic lupus erythematosus	9.58e-05	0.000839	CcSEcCtD
Epoprostenol—Fatigue—Methylprednisolone—systemic lupus erythematosus	9.56e-05	0.000837	CcSEcCtD
Epoprostenol—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	9.54e-05	0.000836	CcSEcCtD
Epoprostenol—Asthenia—Cyclosporine—systemic lupus erythematosus	9.53e-05	0.000835	CcSEcCtD
Epoprostenol—Pain—Triamcinolone—systemic lupus erythematosus	9.5e-05	0.000832	CcSEcCtD
Epoprostenol—PTGIS—Disease—CSK—systemic lupus erythematosus	9.46e-05	0.00165	CbGpPWpGaD
Epoprostenol—Loss of consciousness—Prednisone—systemic lupus erythematosus	9.46e-05	0.000828	CcSEcCtD
Epoprostenol—Hypotension—Betamethasone—systemic lupus erythematosus	9.42e-05	0.000825	CcSEcCtD
Epoprostenol—Hypotension—Dexamethasone—systemic lupus erythematosus	9.42e-05	0.000825	CcSEcCtD
Epoprostenol—Pruritus—Cyclosporine—systemic lupus erythematosus	9.4e-05	0.000823	CcSEcCtD
Epoprostenol—Urticaria—Hydrocortisone—systemic lupus erythematosus	9.38e-05	0.000821	CcSEcCtD
Epoprostenol—Angiopathy—Methotrexate—systemic lupus erythematosus	9.37e-05	0.000821	CcSEcCtD
Epoprostenol—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	9.33e-05	0.000817	CcSEcCtD
Epoprostenol—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	9.33e-05	0.000817	CcSEcCtD
Epoprostenol—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	9.31e-05	0.000816	CcSEcCtD
Epoprostenol—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	9.29e-05	0.000814	CcSEcCtD
Epoprostenol—Chills—Methotrexate—systemic lupus erythematosus	9.27e-05	0.000812	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	9.19e-05	0.000805	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	9.19e-05	0.000805	CcSEcCtD
Epoprostenol—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	9.17e-05	0.000803	CcSEcCtD
Epoprostenol—Arthralgia—Prednisone—systemic lupus erythematosus	9.16e-05	0.000802	CcSEcCtD
Epoprostenol—Myalgia—Prednisone—systemic lupus erythematosus	9.16e-05	0.000802	CcSEcCtD
Epoprostenol—Anxiety—Prednisone—systemic lupus erythematosus	9.13e-05	0.0008	CcSEcCtD
Epoprostenol—Insomnia—Betamethasone—systemic lupus erythematosus	9.12e-05	0.000799	CcSEcCtD
Epoprostenol—Insomnia—Dexamethasone—systemic lupus erythematosus	9.12e-05	0.000799	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	9.1e-05	0.000797	CcSEcCtD
Epoprostenol—Diarrhoea—Cyclosporine—systemic lupus erythematosus	9.09e-05	0.000796	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	9.07e-05	0.000794	CcSEcCtD
Epoprostenol—Paraesthesia—Betamethasone—systemic lupus erythematosus	9.05e-05	0.000793	CcSEcCtD
Epoprostenol—Paraesthesia—Dexamethasone—systemic lupus erythematosus	9.05e-05	0.000793	CcSEcCtD
Epoprostenol—Mental disorder—Methotrexate—systemic lupus erythematosus	9.05e-05	0.000793	CcSEcCtD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	9.03e-05	0.00157	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	9.03e-05	0.00157	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—P2RY12—systemic lupus erythematosus	8.92e-05	0.00155	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	8.92e-05	0.00155	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Prednisolone—systemic lupus erythematosus	8.9e-05	0.00078	CcSEcCtD
Epoprostenol—PTGIS—Disease—CD247—systemic lupus erythematosus	8.89e-05	0.00155	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NAT2—systemic lupus erythematosus	8.89e-05	0.00155	CbGpPWpGaD
Epoprostenol—Dyspepsia—Dexamethasone—systemic lupus erythematosus	8.88e-05	0.000778	CcSEcCtD
Epoprostenol—Dyspepsia—Betamethasone—systemic lupus erythematosus	8.88e-05	0.000778	CcSEcCtD
Epoprostenol—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	8.86e-05	0.000776	CcSEcCtD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.86e-05	0.00154	CbGpPWpGaD
Epoprostenol—Urticaria—Triamcinolone—systemic lupus erythematosus	8.83e-05	0.000773	CcSEcCtD
Epoprostenol—Urticaria—Methylprednisolone—systemic lupus erythematosus	8.81e-05	0.000772	CcSEcCtD
Epoprostenol—Body temperature increased—Triamcinolone—systemic lupus erythematosus	8.78e-05	0.00077	CcSEcCtD
Epoprostenol—Dizziness—Cyclosporine—systemic lupus erythematosus	8.78e-05	0.000769	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisone—systemic lupus erythematosus	8.78e-05	0.000769	CcSEcCtD
Epoprostenol—Oedema—Prednisone—systemic lupus erythematosus	8.78e-05	0.000769	CcSEcCtD
Epoprostenol—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	8.77e-05	0.000768	CcSEcCtD
Epoprostenol—Decreased appetite—Betamethasone—systemic lupus erythematosus	8.77e-05	0.000768	CcSEcCtD
Epoprostenol—Decreased appetite—Dexamethasone—systemic lupus erythematosus	8.77e-05	0.000768	CcSEcCtD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	8.75e-05	0.00152	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	8.73e-05	0.00152	CbGpPWpGaD
Epoprostenol—Infection—Prednisone—systemic lupus erythematosus	8.72e-05	0.000764	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—CCR5—systemic lupus erythematosus	8.71e-05	0.00152	CbGpPWpGaD
Epoprostenol—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	8.71e-05	0.000763	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	8.71e-05	0.000763	CcSEcCtD
Epoprostenol—Back pain—Methotrexate—systemic lupus erythematosus	8.7e-05	0.000762	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	8.7e-05	0.000762	CcSEcCtD
Epoprostenol—Fatigue—Betamethasone—systemic lupus erythematosus	8.69e-05	0.000762	CcSEcCtD
Epoprostenol—Fatigue—Dexamethasone—systemic lupus erythematosus	8.69e-05	0.000762	CcSEcCtD
Epoprostenol—PTGIS—Disease—NCF2—systemic lupus erythematosus	8.65e-05	0.00151	CbGpPWpGaD
Epoprostenol—Shock—Prednisone—systemic lupus erythematosus	8.64e-05	0.000757	CcSEcCtD
Epoprostenol—Pain—Betamethasone—systemic lupus erythematosus	8.62e-05	0.000755	CcSEcCtD
Epoprostenol—Pain—Dexamethasone—systemic lupus erythematosus	8.62e-05	0.000755	CcSEcCtD
Epoprostenol—Nervous system disorder—Prednisone—systemic lupus erythematosus	8.61e-05	0.000754	CcSEcCtD
Epoprostenol—Tachycardia—Prednisone—systemic lupus erythematosus	8.57e-05	0.000751	CcSEcCtD
Epoprostenol—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	8.57e-05	0.00075	CcSEcCtD
Epoprostenol—Skin disorder—Prednisone—systemic lupus erythematosus	8.53e-05	0.000747	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—C3—systemic lupus erythematosus	8.51e-05	0.00148	CbGpPWpGaD
Epoprostenol—Hyperhidrosis—Prednisone—systemic lupus erythematosus	8.49e-05	0.000744	CcSEcCtD
Epoprostenol—Asthenia—Hydrocortisone—systemic lupus erythematosus	8.47e-05	0.000742	CcSEcCtD
Epoprostenol—Vomiting—Cyclosporine—systemic lupus erythematosus	8.44e-05	0.00074	CcSEcCtD
Epoprostenol—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	8.4e-05	0.00146	CbGpPWpGaD
Epoprostenol—Rash—Cyclosporine—systemic lupus erythematosus	8.37e-05	0.000734	CcSEcCtD
Epoprostenol—Anorexia—Prednisone—systemic lupus erythematosus	8.37e-05	0.000733	CcSEcCtD
Epoprostenol—Dermatitis—Cyclosporine—systemic lupus erythematosus	8.37e-05	0.000733	CcSEcCtD
Epoprostenol—Pruritus—Hydrocortisone—systemic lupus erythematosus	8.35e-05	0.000731	CcSEcCtD
Epoprostenol—Headache—Cyclosporine—systemic lupus erythematosus	8.32e-05	0.000729	CcSEcCtD
Epoprostenol—Anaemia—Methotrexate—systemic lupus erythematosus	8.31e-05	0.000728	CcSEcCtD
Epoprostenol—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.28e-05	0.00144	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	8.25e-05	0.000722	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	8.25e-05	0.000722	CcSEcCtD
Epoprostenol—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	8.24e-05	0.000722	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—JAK1—systemic lupus erythematosus	8.22e-05	0.00143	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	8.19e-05	0.000717	CcSEcCtD
Epoprostenol—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	8.17e-05	0.000716	CcSEcCtD
Epoprostenol—Rash—Mycophenolate mofetil—systemic lupus erythematosus	8.17e-05	0.000716	CcSEcCtD
Epoprostenol—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	8.16e-05	0.000715	CcSEcCtD
Epoprostenol—Headache—Mycophenolate mofetil—systemic lupus erythematosus	8.12e-05	0.000711	CcSEcCtD
Epoprostenol—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	8.07e-05	0.000707	CcSEcCtD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	8.05e-05	0.0014	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	8.05e-05	0.0014	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCR5—systemic lupus erythematosus	8.01e-05	0.0014	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCR5—systemic lupus erythematosus	8.01e-05	0.0014	CbGpPWpGaD
Epoprostenol—Urticaria—Betamethasone—systemic lupus erythematosus	8.01e-05	0.000702	CcSEcCtD
Epoprostenol—Urticaria—Dexamethasone—systemic lupus erythematosus	8.01e-05	0.000702	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	8e-05	0.000701	CcSEcCtD
Epoprostenol—Dizziness—Prednisolone—systemic lupus erythematosus	7.99e-05	0.0007	CcSEcCtD
Epoprostenol—Asthenia—Triamcinolone—systemic lupus erythematosus	7.97e-05	0.000698	CcSEcCtD
Epoprostenol—Body temperature increased—Betamethasone—systemic lupus erythematosus	7.97e-05	0.000698	CcSEcCtD
Epoprostenol—Abdominal pain—Dexamethasone—systemic lupus erythematosus	7.97e-05	0.000698	CcSEcCtD
Epoprostenol—Abdominal pain—Betamethasone—systemic lupus erythematosus	7.97e-05	0.000698	CcSEcCtD
Epoprostenol—Body temperature increased—Dexamethasone—systemic lupus erythematosus	7.97e-05	0.000698	CcSEcCtD
Epoprostenol—Asthenia—Methylprednisolone—systemic lupus erythematosus	7.96e-05	0.000697	CcSEcCtD
Epoprostenol—Insomnia—Prednisone—systemic lupus erythematosus	7.94e-05	0.000696	CcSEcCtD
Epoprostenol—Nausea—Cyclosporine—systemic lupus erythematosus	7.89e-05	0.000691	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisone—systemic lupus erythematosus	7.88e-05	0.000691	CcSEcCtD
Epoprostenol—Pruritus—Triamcinolone—systemic lupus erythematosus	7.86e-05	0.000689	CcSEcCtD
Epoprostenol—Cough—Methotrexate—systemic lupus erythematosus	7.85e-05	0.000687	CcSEcCtD
Epoprostenol—Pruritus—Methylprednisolone—systemic lupus erythematosus	7.84e-05	0.000687	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—C3—systemic lupus erythematosus	7.83e-05	0.00136	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—C3—systemic lupus erythematosus	7.83e-05	0.00136	CbGpPWpGaD
Epoprostenol—Dizziness—Hydrocortisone—systemic lupus erythematosus	7.8e-05	0.000684	CcSEcCtD
Epoprostenol—Dyspepsia—Prednisone—systemic lupus erythematosus	7.73e-05	0.000677	CcSEcCtD
Epoprostenol—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	7.69e-05	0.000674	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—IL2RA—systemic lupus erythematosus	7.68e-05	0.00134	CbGpPWpGaD
Epoprostenol—Chest pain—Methotrexate—systemic lupus erythematosus	7.66e-05	0.000671	CcSEcCtD
Epoprostenol—Arthralgia—Methotrexate—systemic lupus erythematosus	7.66e-05	0.000671	CcSEcCtD
Epoprostenol—Myalgia—Methotrexate—systemic lupus erythematosus	7.66e-05	0.000671	CcSEcCtD
Epoprostenol—Decreased appetite—Prednisone—systemic lupus erythematosus	7.63e-05	0.000669	CcSEcCtD
Epoprostenol—Rash—Prednisolone—systemic lupus erythematosus	7.62e-05	0.000667	CcSEcCtD
Epoprostenol—Dermatitis—Prednisolone—systemic lupus erythematosus	7.61e-05	0.000667	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	7.6e-05	0.000666	CcSEcCtD
Epoprostenol—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	7.59e-05	0.000665	CcSEcCtD
Epoprostenol—Fatigue—Prednisone—systemic lupus erythematosus	7.57e-05	0.000663	CcSEcCtD
Epoprostenol—Headache—Prednisolone—systemic lupus erythematosus	7.57e-05	0.000663	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—JAK1—systemic lupus erythematosus	7.56e-05	0.00132	CbGpPWpGaD
Epoprostenol—Constipation—Prednisone—systemic lupus erythematosus	7.51e-05	0.000658	CcSEcCtD
Epoprostenol—Vomiting—Hydrocortisone—systemic lupus erythematosus	7.5e-05	0.000657	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—F2—systemic lupus erythematosus	7.47e-05	0.0013	CbGpPWpGaD
Epoprostenol—Rash—Hydrocortisone—systemic lupus erythematosus	7.44e-05	0.000652	CcSEcCtD
Epoprostenol—Dermatitis—Hydrocortisone—systemic lupus erythematosus	7.43e-05	0.000651	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	7.42e-05	0.00129	CbGpPWpGaD
Epoprostenol—Confusional state—Methotrexate—systemic lupus erythematosus	7.4e-05	0.000648	CcSEcCtD
Epoprostenol—Headache—Hydrocortisone—systemic lupus erythematosus	7.39e-05	0.000648	CcSEcCtD
Epoprostenol—Dizziness—Triamcinolone—systemic lupus erythematosus	7.35e-05	0.000644	CcSEcCtD
Epoprostenol—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	7.34e-05	0.000643	CcSEcCtD
Epoprostenol—Dizziness—Methylprednisolone—systemic lupus erythematosus	7.33e-05	0.000642	CcSEcCtD
Epoprostenol—Infection—Methotrexate—systemic lupus erythematosus	7.29e-05	0.000639	CcSEcCtD
Epoprostenol—Asthenia—Dexamethasone—systemic lupus erythematosus	7.23e-05	0.000634	CcSEcCtD
Epoprostenol—Asthenia—Betamethasone—systemic lupus erythematosus	7.23e-05	0.000634	CcSEcCtD
Epoprostenol—Nervous system disorder—Methotrexate—systemic lupus erythematosus	7.2e-05	0.00063	CcSEcCtD
Epoprostenol—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	7.19e-05	0.000629	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	7.18e-05	0.00125	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	7.18e-05	0.000629	CcSEcCtD
Epoprostenol—Nausea—Prednisolone—systemic lupus erythematosus	7.18e-05	0.000629	CcSEcCtD
Epoprostenol—Pruritus—Dexamethasone—systemic lupus erythematosus	7.13e-05	0.000625	CcSEcCtD
Epoprostenol—Pruritus—Betamethasone—systemic lupus erythematosus	7.13e-05	0.000625	CcSEcCtD
Epoprostenol—Skin disorder—Methotrexate—systemic lupus erythematosus	7.13e-05	0.000624	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000621	CcSEcCtD
Epoprostenol—Vomiting—Triamcinolone—systemic lupus erythematosus	7.07e-05	0.000619	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.06e-05	0.00123	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2RA—systemic lupus erythematosus	7.06e-05	0.00123	CbGpPWpGaD
Epoprostenol—Vomiting—Methylprednisolone—systemic lupus erythematosus	7.05e-05	0.000618	CcSEcCtD
Epoprostenol—Nausea—Hydrocortisone—systemic lupus erythematosus	7.01e-05	0.000614	CcSEcCtD
Epoprostenol—Rash—Triamcinolone—systemic lupus erythematosus	7.01e-05	0.000614	CcSEcCtD
Epoprostenol—Dermatitis—Triamcinolone—systemic lupus erythematosus	7e-05	0.000613	CcSEcCtD
Epoprostenol—Anorexia—Methotrexate—systemic lupus erythematosus	7e-05	0.000613	CcSEcCtD
Epoprostenol—Rash—Methylprednisolone—systemic lupus erythematosus	6.99e-05	0.000612	CcSEcCtD
Epoprostenol—Dermatitis—Methylprednisolone—systemic lupus erythematosus	6.98e-05	0.000612	CcSEcCtD
Epoprostenol—Urticaria—Prednisone—systemic lupus erythematosus	6.98e-05	0.000611	CcSEcCtD
Epoprostenol—Headache—Triamcinolone—systemic lupus erythematosus	6.96e-05	0.00061	CcSEcCtD
Epoprostenol—Headache—Methylprednisolone—systemic lupus erythematosus	6.95e-05	0.000609	CcSEcCtD
Epoprostenol—Abdominal pain—Prednisone—systemic lupus erythematosus	6.94e-05	0.000608	CcSEcCtD
Epoprostenol—Body temperature increased—Prednisone—systemic lupus erythematosus	6.94e-05	0.000608	CcSEcCtD
Epoprostenol—Diarrhoea—Betamethasone—systemic lupus erythematosus	6.9e-05	0.000604	CcSEcCtD
Epoprostenol—Diarrhoea—Dexamethasone—systemic lupus erythematosus	6.9e-05	0.000604	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—F2—systemic lupus erythematosus	6.88e-05	0.0012	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—F2—systemic lupus erythematosus	6.88e-05	0.0012	CbGpPWpGaD
Epoprostenol—Hypotension—Methotrexate—systemic lupus erythematosus	6.86e-05	0.000601	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	6.81e-05	0.00119	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—JUNB—systemic lupus erythematosus	6.79e-05	0.00118	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.7e-05	0.00117	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	6.69e-05	0.000586	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—F2—systemic lupus erythematosus	6.68e-05	0.00116	CbGpPWpGaD
Epoprostenol—Dizziness—Betamethasone—systemic lupus erythematosus	6.67e-05	0.000584	CcSEcCtD
Epoprostenol—Dizziness—Dexamethasone—systemic lupus erythematosus	6.67e-05	0.000584	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.66e-05	0.00116	CbGpPWpGaD
Epoprostenol—Insomnia—Methotrexate—systemic lupus erythematosus	6.64e-05	0.000581	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	6.61e-05	0.00115	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	6.61e-05	0.00115	CbGpPWpGaD
Epoprostenol—Nausea—Triamcinolone—systemic lupus erythematosus	6.6e-05	0.000578	CcSEcCtD
Epoprostenol—Paraesthesia—Methotrexate—systemic lupus erythematosus	6.59e-05	0.000577	CcSEcCtD
Epoprostenol—Nausea—Methylprednisolone—systemic lupus erythematosus	6.59e-05	0.000577	CcSEcCtD
Epoprostenol—Dyspnoea—Methotrexate—systemic lupus erythematosus	6.54e-05	0.000573	CcSEcCtD
Epoprostenol—Somnolence—Methotrexate—systemic lupus erythematosus	6.52e-05	0.000572	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL12—systemic lupus erythematosus	6.52e-05	0.00114	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Prednisone—systemic lupus erythematosus	6.47e-05	0.000567	CcSEcCtD
Epoprostenol—Dyspepsia—Methotrexate—systemic lupus erythematosus	6.46e-05	0.000566	CcSEcCtD
Epoprostenol—Vomiting—Betamethasone—systemic lupus erythematosus	6.41e-05	0.000562	CcSEcCtD
Epoprostenol—Vomiting—Dexamethasone—systemic lupus erythematosus	6.41e-05	0.000562	CcSEcCtD
Epoprostenol—Decreased appetite—Methotrexate—systemic lupus erythematosus	6.38e-05	0.000559	CcSEcCtD
Epoprostenol—Rash—Betamethasone—systemic lupus erythematosus	6.36e-05	0.000557	CcSEcCtD
Epoprostenol—Rash—Dexamethasone—systemic lupus erythematosus	6.36e-05	0.000557	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.35e-05	0.00111	CbGpPWpGaD
Epoprostenol—Dermatitis—Betamethasone—systemic lupus erythematosus	6.35e-05	0.000556	CcSEcCtD
Epoprostenol—Dermatitis—Dexamethasone—systemic lupus erythematosus	6.35e-05	0.000556	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	6.34e-05	0.000555	CcSEcCtD
Epoprostenol—Fatigue—Methotrexate—systemic lupus erythematosus	6.33e-05	0.000554	CcSEcCtD
Epoprostenol—Headache—Dexamethasone—systemic lupus erythematosus	6.32e-05	0.000553	CcSEcCtD
Epoprostenol—Headache—Betamethasone—systemic lupus erythematosus	6.32e-05	0.000553	CcSEcCtD
Epoprostenol—Asthenia—Prednisone—systemic lupus erythematosus	6.3e-05	0.000552	CcSEcCtD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.28e-05	0.00109	CbGpPWpGaD
Epoprostenol—Pain—Methotrexate—systemic lupus erythematosus	6.28e-05	0.00055	CcSEcCtD
Epoprostenol—PTGIS—Disease—PRL—systemic lupus erythematosus	6.25e-05	0.00109	CbGpPWpGaD
Epoprostenol—Pruritus—Prednisone—systemic lupus erythematosus	6.21e-05	0.000544	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.16e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.16e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—F2—systemic lupus erythematosus	6.15e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.13e-05	0.00107	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.13e-05	0.00107	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	6.08e-05	0.00106	CbGpPWpGaD
Epoprostenol—Diarrhoea—Prednisone—systemic lupus erythematosus	6.01e-05	0.000526	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	6e-05	0.00105	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL12—systemic lupus erythematosus	6e-05	0.00105	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6e-05	0.000526	CcSEcCtD
Epoprostenol—Nausea—Betamethasone—systemic lupus erythematosus	5.99e-05	0.000525	CcSEcCtD
Epoprostenol—Nausea—Dexamethasone—systemic lupus erythematosus	5.99e-05	0.000525	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—TLR9—systemic lupus erythematosus	5.91e-05	0.00103	CbGpPWpGaD
Epoprostenol—Urticaria—Methotrexate—systemic lupus erythematosus	5.83e-05	0.000511	CcSEcCtD
Epoprostenol—Dizziness—Prednisone—systemic lupus erythematosus	5.81e-05	0.000509	CcSEcCtD
Epoprostenol—Body temperature increased—Methotrexate—systemic lupus erythematosus	5.8e-05	0.000508	CcSEcCtD
Epoprostenol—Abdominal pain—Methotrexate—systemic lupus erythematosus	5.8e-05	0.000508	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	5.6e-05	0.000975	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	5.6e-05	0.000975	CbGpPWpGaD
Epoprostenol—Vomiting—Prednisone—systemic lupus erythematosus	5.58e-05	0.000489	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.56e-05	0.000968	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—ALB—systemic lupus erythematosus	5.55e-05	0.000966	CbGpPWpGaD
Epoprostenol—Rash—Prednisone—systemic lupus erythematosus	5.54e-05	0.000485	CcSEcCtD
Epoprostenol—Dermatitis—Prednisone—systemic lupus erythematosus	5.53e-05	0.000485	CcSEcCtD
Epoprostenol—Headache—Prednisone—systemic lupus erythematosus	5.5e-05	0.000482	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—TLR9—systemic lupus erythematosus	5.44e-05	0.000947	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TLR9—systemic lupus erythematosus	5.44e-05	0.000947	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.41e-05	0.000474	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.41e-05	0.000941	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—NOS3—systemic lupus erythematosus	5.31e-05	0.000924	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CSK—systemic lupus erythematosus	5.27e-05	0.000917	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—P2RY12—systemic lupus erythematosus	5.27e-05	0.000917	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—P2RY12—systemic lupus erythematosus	5.27e-05	0.000917	CbGpPWpGaD
Epoprostenol—Asthenia—Methotrexate—systemic lupus erythematosus	5.27e-05	0.000461	CcSEcCtD
Epoprostenol—Nausea—Prednisone—systemic lupus erythematosus	5.22e-05	0.000457	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—JAK1—systemic lupus erythematosus	5.19e-05	0.000904	CbGpPWpGaD
Epoprostenol—Pruritus—Methotrexate—systemic lupus erythematosus	5.19e-05	0.000455	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—ALB—systemic lupus erythematosus	5.11e-05	0.000889	CbGpPWpGaD
Epoprostenol—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.02e-05	0.00044	CcSEcCtD
Epoprostenol—PTGIS—Disease—JAK1—systemic lupus erythematosus	5e-05	0.000871	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—RXRA—systemic lupus erythematosus	4.98e-05	0.000868	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.98e-05	0.000866	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.98e-05	0.000866	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.92e-05	0.000857	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—NOS3—systemic lupus erythematosus	4.88e-05	0.000851	CbGpPWpGaD
Epoprostenol—Dizziness—Methotrexate—systemic lupus erythematosus	4.85e-05	0.000425	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.85e-05	0.000845	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CSK—systemic lupus erythematosus	4.85e-05	0.000844	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CSK—systemic lupus erythematosus	4.85e-05	0.000844	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	4.83e-05	0.000841	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NCF2—systemic lupus erythematosus	4.82e-05	0.000839	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—C3—systemic lupus erythematosus	4.81e-05	0.000838	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LYN—systemic lupus erythematosus	4.79e-05	0.000834	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.78e-05	0.000832	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.78e-05	0.000832	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CCR5—systemic lupus erythematosus	4.74e-05	0.000825	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.72e-05	0.000821	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	4.71e-05	0.00082	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.7e-05	0.000818	CbGpPWpGaD
Epoprostenol—Vomiting—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000409	CcSEcCtD
Epoprostenol—Rash—Methotrexate—systemic lupus erythematosus	4.63e-05	0.000405	CcSEcCtD
Epoprostenol—Dermatitis—Methotrexate—systemic lupus erythematosus	4.62e-05	0.000405	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.62e-05	0.000805	CbGpPWpGaD
Epoprostenol—Headache—Methotrexate—systemic lupus erythematosus	4.6e-05	0.000403	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.53e-05	0.000789	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.53e-05	0.000789	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL2—systemic lupus erythematosus	4.5e-05	0.000784	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.47e-05	0.000778	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.46e-05	0.000777	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.46e-05	0.000777	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NCF2—systemic lupus erythematosus	4.43e-05	0.000772	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NCF2—systemic lupus erythematosus	4.43e-05	0.000772	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—C3—systemic lupus erythematosus	4.43e-05	0.000771	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—C3—systemic lupus erythematosus	4.43e-05	0.000771	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LYN—systemic lupus erythematosus	4.41e-05	0.000767	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LYN—systemic lupus erythematosus	4.41e-05	0.000767	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.4e-05	0.000767	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—C3—systemic lupus erythematosus	4.37e-05	0.000761	CbGpPWpGaD
Epoprostenol—Nausea—Methotrexate—systemic lupus erythematosus	4.36e-05	0.000382	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.34e-05	0.000756	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.34e-05	0.000756	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.32e-05	0.000753	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.32e-05	0.000753	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—F2—systemic lupus erythematosus	4.22e-05	0.000735	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2—systemic lupus erythematosus	4.14e-05	0.000721	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.11e-05	0.000716	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.11e-05	0.000716	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.05e-05	0.000706	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.05e-05	0.000706	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—EP300—systemic lupus erythematosus	4.04e-05	0.000703	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—C3—systemic lupus erythematosus	4.02e-05	0.0007	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—C3—systemic lupus erythematosus	4.02e-05	0.0007	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD80—systemic lupus erythematosus	3.9e-05	0.000679	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—F2—systemic lupus erythematosus	3.89e-05	0.000677	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—F2—systemic lupus erythematosus	3.89e-05	0.000677	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.85e-05	0.000671	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—F2—systemic lupus erythematosus	3.83e-05	0.000668	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VEGFA—systemic lupus erythematosus	3.82e-05	0.000666	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—JUNB—systemic lupus erythematosus	3.78e-05	0.000658	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—EP300—systemic lupus erythematosus	3.72e-05	0.000647	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.59e-05	0.000626	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.55e-05	0.000617	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.55e-05	0.000617	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—F2—systemic lupus erythematosus	3.53e-05	0.000615	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—F2—systemic lupus erythematosus	3.53e-05	0.000615	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—systemic lupus erythematosus	3.52e-05	0.000613	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TGFB1—systemic lupus erythematosus	3.51e-05	0.000611	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRL—systemic lupus erythematosus	3.48e-05	0.000607	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—JUNB—systemic lupus erythematosus	3.48e-05	0.000606	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—JUNB—systemic lupus erythematosus	3.48e-05	0.000606	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.42e-05	0.000595	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.31e-05	0.000576	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.31e-05	0.000576	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TYK2—systemic lupus erythematosus	3.29e-05	0.000573	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS3—systemic lupus erythematosus	3.23e-05	0.000563	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TGFB1—systemic lupus erythematosus	3.23e-05	0.000562	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRL—systemic lupus erythematosus	3.21e-05	0.000558	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRL—systemic lupus erythematosus	3.21e-05	0.000558	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARG—systemic lupus erythematosus	3.15e-05	0.000548	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.15e-05	0.000548	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.15e-05	0.000548	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.1e-05	0.00054	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD4—systemic lupus erythematosus	2.98e-05	0.000518	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—systemic lupus erythematosus	2.96e-05	0.000515	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.86e-05	0.000497	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.86e-05	0.000497	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.84e-05	0.000495	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALB—systemic lupus erythematosus	2.83e-05	0.000493	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CDKN1B—systemic lupus erythematosus	2.8e-05	0.000487	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—JAK1—systemic lupus erythematosus	2.79e-05	0.000485	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NOS3—systemic lupus erythematosus	2.71e-05	0.000471	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR5—systemic lupus erythematosus	2.64e-05	0.00046	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.62e-05	0.000456	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.62e-05	0.000456	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.6e-05	0.000453	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CDKN1A—systemic lupus erythematosus	2.58e-05	0.00045	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—systemic lupus erythematosus	2.58e-05	0.00045	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—C3—systemic lupus erythematosus	2.58e-05	0.000449	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—JAK1—systemic lupus erythematosus	2.56e-05	0.000447	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.56e-05	0.000447	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—systemic lupus erythematosus	2.47e-05	0.000431	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EP300—systemic lupus erythematosus	2.46e-05	0.000428	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR5—systemic lupus erythematosus	2.43e-05	0.000423	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.43e-05	0.000423	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.39e-05	0.000417	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.39e-05	0.000417	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—systemic lupus erythematosus	2.38e-05	0.000414	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—systemic lupus erythematosus	2.38e-05	0.000414	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—C3—systemic lupus erythematosus	2.37e-05	0.000413	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—C3—systemic lupus erythematosus	2.37e-05	0.000413	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—F2—systemic lupus erythematosus	2.27e-05	0.000394	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CD80—systemic lupus erythematosus	2.17e-05	0.000378	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—systemic lupus erythematosus	2.14e-05	0.000372	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—F2—systemic lupus erythematosus	2.08e-05	0.000363	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—F2—systemic lupus erythematosus	2.08e-05	0.000363	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—EP300—systemic lupus erythematosus	2.06e-05	0.000358	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—systemic lupus erythematosus	2.02e-05	0.000352	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CD80—systemic lupus erythematosus	2e-05	0.000348	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CD80—systemic lupus erythematosus	2e-05	0.000348	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.86e-05	0.000324	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—systemic lupus erythematosus	1.86e-05	0.000324	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TYK2—systemic lupus erythematosus	1.83e-05	0.000319	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.81e-05	0.000315	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—systemic lupus erythematosus	1.8e-05	0.000313	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TYK2—systemic lupus erythematosus	1.69e-05	0.000294	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.69e-05	0.000294	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.66e-05	0.000288	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—systemic lupus erythematosus	1.66e-05	0.000288	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—systemic lupus erythematosus	1.61e-05	0.00028	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.56e-05	0.000271	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—systemic lupus erythematosus	1.53e-05	0.000266	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—systemic lupus erythematosus	1.52e-05	0.000264	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—systemic lupus erythematosus	1.44e-05	0.000251	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.44e-05	0.000251	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.44e-05	0.00025	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.43e-05	0.00025	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.43e-05	0.00025	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—systemic lupus erythematosus	1.4e-05	0.000244	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—systemic lupus erythematosus	1.4e-05	0.000244	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—systemic lupus erythematosus	1.4e-05	0.000243	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.4e-05	0.000243	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EP300—systemic lupus erythematosus	1.37e-05	0.000238	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.33e-05	0.000231	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—systemic lupus erythematosus	1.33e-05	0.000231	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.32e-05	0.000231	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.32e-05	0.000231	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.3e-05	0.000226	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EP300—systemic lupus erythematosus	1.26e-05	0.000219	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EP300—systemic lupus erythematosus	1.26e-05	0.000219	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.19e-05	0.000208	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.19e-05	0.000208	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.19e-05	0.000207	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.14e-05	0.000199	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.1e-05	0.000191	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.1e-05	0.000191	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.03e-05	0.000179	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.98e-06	0.000156	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—systemic lupus erythematosus	8.97e-06	0.000156	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—systemic lupus erythematosus	8.25e-06	0.000144	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—systemic lupus erythematosus	8.25e-06	0.000144	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	8.05e-06	0.00014	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.47e-06	0.00013	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.08e-06	8.85e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	4.57e-06	7.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.37e-06	7.61e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4e-06	6.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.33e-06	5.79e-05	CbGpPWpGaD
